Login to Your Account



Sanofi, Regeneron win approval for sarilumab in RA

By Michael Fitzhugh
Staff Writer

Tuesday, May 23, 2017

Following an initial rejection over manufacturing issues, FDA approval for the rheumatoid arthritis (RA) therapy sarilumab arrived late Monday.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription